NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Penny A. Asbell, MD, FACS, MBA, explains that while MRSA has decreased, it is often still multidrug resistant.
“There’s actually some good news here,” Asbell said in reference to new data in the 14-year update to the ARMOR surveillance study. Staphylococcus aureus has actually gone down about 50%, and coagulase-negative Staph is 40% methicillin resistant. “But the real take-home message is that if an organism is methicillin resistant, whether it’s Staph aureus or coagulase-negative Staph,